Vivoryon Therapeutics N.V.

ENXTAM:VVY Stock Report

Market Cap: €14.9m

Vivoryon Therapeutics Management

Management criteria checks 1/4

Vivoryon Therapeutics' CEO is Frank Weber, appointed in Aug 2023, has a tenure of less than a year. directly owns 0.13% of the company’s shares, worth €19.35K. The average tenure of the management team and the board of directors is 5.5 years and 1.2 years respectively.

Key information

Frank Weber

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.1%
Management average tenure5.5yrs
Board average tenure1.2yrs

Recent management updates

Recent updates

Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

May 04
Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

Sep 02
Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Jan 26
Here's Why We're Not Too Worried About Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

Sep 16
Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

We Think Vivoryon Therapeutics (AMS:VVY) Can Afford To Drive Business Growth

May 10
We Think Vivoryon Therapeutics (AMS:VVY) Can Afford To Drive Business Growth

Is Vivoryon Therapeutics N.V.'s (AMS:VVY) Shareholder Ownership Skewed Towards Insiders?

Mar 11
Is Vivoryon Therapeutics N.V.'s (AMS:VVY) Shareholder Ownership Skewed Towards Insiders?

We're Hopeful That Vivoryon Therapeutics (AMS:VVY) Will Use Its Cash Wisely

Jan 14
We're Hopeful That Vivoryon Therapeutics (AMS:VVY) Will Use Its Cash Wisely

CEO

Frank Weber (63 yo)

less than a year

Tenure

Dr. Frank T. Weber M. D. has been Chief Medical and Development Officer (CMDO) of Vivoryon Vivoryon Therapeutics N. V. (formerly known as Vivoryon Therapeutics AG & Probiodrug AG) since September 1, 2019....


Leadership Team

NamePositionTenureCompensationOwnership
Michael Schaeffer
Chief Business Officer5.5yrs€1.06m0%
€ 0
Frank Weber
Chairman of the Management Boardless than a yearno data0.13%
€ 19.4k
Anne Doering
CSO & Investor Relations Officerless than a yearno datano data
Manuela Bader
Director of Investor Relations & Communicationsno datano datano data
Konrad Glund
Co-Founder & Advisorno data€222.11kno data
Hendrik Liebers
Advisorno data€319.20kno data

5.5yrs

Average Tenure

58.5yo

Average Age

Experienced Management: VVY's management team is seasoned and experienced (5.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Schaeffer
Chief Business Officerno data€1.06m0%
€ 0
Frank Weber
Chairman of the Management Boardless than a yearno data0.13%
€ 19.4k
Anne Doering
CSO & Investor Relations Officerless than a yearno datano data
Erich Platzer
Independent Non-Executive Chairmanno data€222.00kno data
Charlotte Lohmann
Independent Non-Executive Directorno data€209.00kno data
Samir Shah
Independent Non-Executive Director1.8yrs€242.00kno data
Claudia Riedl
Independent Non-Executive Director1.8yrs€156.00kno data

1.2yrs

Average Tenure

57.5yo

Average Age

Experienced Board: VVY's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.